{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:15:27Z","timestamp":1794118527135,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01422-8","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T09:02:30Z","timestamp":1752829350000},"page":"2181-2195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-8505","authenticated-orcid":false,"given":"Ningqiang","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5672-6930","authenticated-orcid":false,"given":"Mohamad-Gabriel","family":"Alameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-233X","authenticated-orcid":false,"given":"Rakan","family":"El-Mayta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6276-7502","authenticated-orcid":false,"given":"Emily L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Palanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangqiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-5222","authenticated-orcid":false,"given":"Xuexiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1336","authenticated-orcid":false,"given":"Lulu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-8111","authenticated-orcid":false,"given":"Junchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-7678","authenticated-orcid":false,"given":"Christian G.","family":"Figueroa-Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-6510","authenticated-orcid":false,"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-7352","authenticated-orcid":false,"given":"Jinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"1422_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1422_CR2","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"1422_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"1422_CR4","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","volume":"52","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R. & van der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc. Chem. Res. 52, 2435\u20132444 (2019).","journal-title":"Acc. Chem. Res."},{"key":"1422_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis, P. R. & Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther. 25, 1467\u20131475 (2017).","journal-title":"Mol. Ther."},{"key":"1422_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"1422_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","volume":"3","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Nanotechnology-based mRNA vaccines. Nat. Rev. Methods Primers 3, 63 (2023).","journal-title":"Nat. Rev. Methods Primers"},{"key":"1422_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1422_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","volume":"48","author":"BZ Igy\u00e1rt\u00f3","year":"2021","unstructured":"Igy\u00e1rt\u00f3, B. Z., Jacobsen, S. & Ndeupen, S. Future considerations for the mRNA-lipid nanoparticle vaccine platform. Curr. Opin. Virol. 48, 65\u201372 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"1422_CR10","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","volume":"24","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen, S. et al. The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24, 103479 (2021).","journal-title":"iScience"},{"key":"1422_CR11","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","volume":"30","author":"SM Moghimi","year":"2022","unstructured":"Moghimi, S. M. & Simberg, D. Pro-inflammatory concerns with lipid nanoparticles. Mol. Ther. 30, 2109\u20132110 (2022).","journal-title":"Mol. Ther."},{"key":"1422_CR12","doi-asserted-by":"publisher","first-page":"113900","DOI":"10.1016\/j.addr.2021.113900","volume":"176","author":"A-K Minnaert","year":"2021","unstructured":"Minnaert, A.-K. et al. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across. Adv. Drug Deliv. Rev. 176, 113900 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1422_CR13","doi-asserted-by":"publisher","first-page":"12996","DOI":"10.1073\/pnas.1106379108","volume":"108","author":"DJ Siegwart","year":"2011","unstructured":"Siegwart, D. J. et al. Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc. Natl Acad. Sci. USA 108, 12996\u201313001 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1422_CR14","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2021","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2021).","journal-title":"Acc. Chem. Res."},{"key":"1422_CR16","doi-asserted-by":"publisher","first-page":"e2307798120","DOI":"10.1073\/pnas.2307798120","volume":"121","author":"J Witten","year":"2024","unstructured":"Witten, J., Hu, Y., Langer, R. & Anderson, D. G. Recent advances in nanoparticulate RNA delivery systems. Proc. Natl Acad. Sci. USA 121, e2307798120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1422_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1055\/s-1973-22294","volume":"1973","author":"M Tramontini","year":"1973","unstructured":"Tramontini, M. Advances in the chemistry of Mannich bases. Synthesis 1973, 703\u2013775 (1973).","journal-title":"Synthesis"},{"key":"1422_CR18","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0040-4020(01)89752-0","volume":"46","author":"M Tramontini","year":"1990","unstructured":"Tramontini, M. & Angiolini, L. Further advances in the chemistry of Mannich bases. Tetrahedron 46, 1791\u20131837 (1990).","journal-title":"Tetrahedron"},{"key":"1422_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0032-3861(88)90132-2","volume":"29","author":"M Tramontini","year":"1988","unstructured":"Tramontini, M., Angiolini, L. & Ghedini, N. Mannich bases in polymer chemistry. Polymer 29, 771\u2013788 (1988).","journal-title":"Polymer"},{"key":"1422_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cofs.2016.02.002","volume":"8","author":"H Zhang","year":"2016","unstructured":"Zhang, H. & Tsao, R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr. Opin. Food Sci. 8, 33\u201342 (2016).","journal-title":"Curr. Opin. Food Sci."},{"key":"1422_CR21","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/antiox10071044","volume":"10","author":"M Bucciantini","year":"2021","unstructured":"Bucciantini, M., Leri, M., Nardiello, P., Casamenti, F. & Stefani, M. Olive polyphenols: antioxidant and anti-inflammatory properties. Antioxidants 10, 1044 (2021).","journal-title":"Antioxidants"},{"key":"1422_CR22","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/nu10111618","volume":"10","author":"N Yahfoufi","year":"2018","unstructured":"Yahfoufi, N., Alsadi, N., Jambi, M. & Matar, C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 10, 1618 (2018).","journal-title":"Nutrients"},{"key":"1422_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ars.2010.3699","volume":"15","author":"CM Grant","year":"2011","unstructured":"Grant, C. M. Regulation of translation by hydrogen peroxide. Antioxid. Redox Signal. 15, 191\u2013203 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"1422_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drudis.2015.07.009","volume":"21","author":"J Devoldere","year":"2016","unstructured":"Devoldere, J., Dewitte, H., De Smedt, S. C. & Remaut, K. Evading innate immunity in nonviral mRNA delivery: don\u2019t shoot the messenger. Drug Discov. Today 21, 11\u201325 (2016).","journal-title":"Drug Discov. Today"},{"key":"1422_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","volume":"26","author":"S Linares-Fern\u00e1ndez","year":"2020","unstructured":"Linares-Fern\u00e1ndez, S., Lacroix, C., Exposito, J.-Y. & Verrier, B. Tailoring mRNA vaccine to balance innate\/adaptive immune response. Trends Mol. Med. 26, 311\u2013323 (2020).","journal-title":"Trends Mol. Med."},{"key":"1422_CR26","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1039\/D2BM00883A","volume":"10","author":"J Forster Iii","year":"2022","unstructured":"Forster Iii, J., Nandi, D. & Kulkarni, A. mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency. Biomater. Sci. 10, 5566\u20135582 (2022).","journal-title":"Biomater. Sci."},{"key":"1422_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cdd.2014.150","volume":"22","author":"G Filomeni","year":"2015","unstructured":"Filomeni, G., De Zio, D. & Cecconi, F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 22, 377\u2013388 (2015).","journal-title":"Cell Death Differ."},{"key":"1422_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"K Dasuri","year":"2013","unstructured":"Dasuri, K., Zhang, L. & Keller, J. N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 62, 170\u2013185 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"1422_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1422_CR30","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"1422_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1422_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the physiology of FGF21. Annu. Rev. Physiol. 78, 223\u2013241 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"1422_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","volume":"3","author":"KH Flippo","year":"2021","unstructured":"Flippo, K. H. & Potthoff, M. J. Metabolic messengers: FGF21. Nat. Metab. 3, 309\u2013317 (2021).","journal-title":"Nat. Metab."},{"key":"1422_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng, L., Lam, K. S. & Xu, A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat. Rev. Endocrinol. 16, 654\u2013667 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1422_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708791","volume":"10","author":"V Jimenez","year":"2018","unstructured":"Jimenez, V. et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol. Med. 10, e8791 (2018).","journal-title":"EMBO Mol. Med."},{"key":"1422_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41565-020-00782-3","volume":"15","author":"N Gong","year":"2020","unstructured":"Gong, N. et al. Proton-driven transformable nanovaccine for cancer immunotherapy. Nat. Nanotechnol. 15, 1053\u20131064 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1422_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1128\/CVI.00286-10","volume":"18","author":"L Buonaguro","year":"2011","unstructured":"Buonaguro, L., Petrizzo, A., Tornesello, M. L. & Buonaguro, F. M. Translating tumor antigens into cancer vaccines. Clin. Vaccine Immunol. 18, 23\u201334 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"1422_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","volume":"18","author":"E Blass","year":"2021","unstructured":"Blass, E. & Ott, P. A. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines. Nat. Rev. Clin. Oncol. 18, 215\u2013229 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1422_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"1422_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144\u2013150 (2023).","journal-title":"Nature"},{"key":"1422_CR41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","volume":"27","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma. Nat. Med. 27, 515\u2013525 (2021).","journal-title":"Nat. Med."},{"key":"1422_CR42","doi-asserted-by":"publisher","first-page":"983000","DOI":"10.3389\/fimmu.2022.983000","volume":"13","author":"C Sittplangkoon","year":"2022","unstructured":"Sittplangkoon, C. et al. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Front. Immunol. 13, 983000 (2022).","journal-title":"Front. Immunol."},{"key":"1422_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","volume":"321","author":"A Berger","year":"2000","unstructured":"Berger, A. Th1 and Th2 responses: what are they? Br. Med. J. 321, 424 (2000).","journal-title":"Br. Med. J."},{"key":"1422_CR44","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","volume":"146","author":"PM Kaye","year":"1991","unstructured":"Kaye, P. M., Curry, A. J. & Blackwell, J. M. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763\u20132770 (1991).","journal-title":"J. Immunol."},{"key":"1422_CR45","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843\u2013850 (2007).","journal-title":"Nat. Med."},{"key":"1422_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20062363","volume":"204","author":"ML Precopio","year":"2007","unstructured":"Precopio, M. L. et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. J. Exp. Med. 204, 1405\u20131416 (2007).","journal-title":"J. Exp. Med."},{"key":"1422_CR47","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/vaccines9121503","volume":"9","author":"G Giannotta","year":"2021","unstructured":"Giannotta, G. & Giannotta, N. mRNA COVID-19 vaccines and long-lived plasma cells: a complicated relationship. Vaccines 9, 1503 (2021).","journal-title":"Vaccines"},{"key":"1422_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","volume":"371","author":"C Krienke","year":"2021","unstructured":"Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145\u2013153 (2021).","journal-title":"Science"},{"key":"1422_CR49","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M. & Yeo, G. W. Base editing: advances and therapeutic opportunities. Nat. Rev. Drug Discov. 19, 839\u2013859 (2020).","journal-title":"Nat. Rev. Drug Discov."}],"updated-by":[{"DOI":"10.1038\/s41551-025-01486-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000}}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01422-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:03:08Z","timestamp":1766055788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01422-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":49,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01422-8","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41551-025-01486-6","URL":"https:\/\/doi.org\/10.1038\/s41551-025-01486-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.G. and M.J.M. have filed a patent application related to this study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}